my-server
← Wiki

Marcus Hacker

Marcus Hacker (b. 19 October 1969 in Eggenfelden, Germany) is a university professor and specialist in Nuclear medicine at the Medical University of Vienna (Vienna, Austria).

Career

After completing the medicine studies in Erlangen and Munich from 1989 to 1998 and completing his dissertation in 2002, Marcus Hacker was recognized as a specialist in nuclear medicine in 2004. From 2007, he worked as a senior physician for cardiovascular imaging and deputy head of PET/CT at the clinic of the LMU Munich, where he qualified as a professor in 2008 and was promoted to senior physician and deputy director in 2009. In 2012, Marcus Hacker was appointed as an adjunct professor at the LMU Munich. Since 2013, he has been a university professor for nuclear medicine and head of the Clinical Department of Nuclear Medicine at the Medical University of Vienna.

Scientific Achievements

Marcus Hacker is involved in the establishment of new individualized diagnostic and treatment procedures in nuclear medicine, particularly in cardiovascular, oncological and neuropsychiatric applications. The focus here is on in-vivo tissue characterization and the selection of suitable radiopharmaceuticals for patient-related individual risk assessment.In translational research, Marcus Hacker established new biomarkers for the identification of mechanistic relationships and for translation from cell or animal models to humans.

As for October 2024, Marcus Hacker is author of 504 original scientific papers with 14,106 citations (excluding self-citations), and 28 book chapters. The key areas of his academic interest are theranostics, PET and SPECT Hybrid Imaging, and Network- and Prevention Medicine.

Academic Awards

Memberships

  • 2022 - 2024     Speaker Medical Imaging Cluster, Medical University of Vienna, Austria;
  • 2017 - 2018     Chair of the Nuclear Cardiology Working Group (AG20) of the German Cardiac Society;
  • 2016 - 2018     Secretary and member of the executive board and chairman of the Cardiovascular Nuclear Medicine Working Group of the ;
  • 2018             Treasurer and Member of the Board of the Austrian Platform for Personalized Medicine;
  • 2016 President of the Austrian Society of Nuclear Medicine and Molecular Imaging;
  • 2014 - 2017     Chair of the Cardiovascular Committee of the European Association of Nuclear Medicine (Vienna, Austria);
  • 2014 Member of the Scientific Committee at the Germany Multiple CME Sessions at the Annual Congresses of the European Association of Nuclear Medicine (Hannover, Germany);
  • 2013               Head of the Research Group for Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine;
  • 2013                Member of the Board of Directors of the Austrian Society of Nuclear Medicine and Molecular Imaging;
  • 2013                Sub-Chair of the Cardiovascular Committee at the Annual Congress of the Society of Nuclear Medicine in Vancouver, Canada;
  • 2013                 Voted Member of the Board of Directors of the German Society of Nuclear Medicine;
  • 2012                 Member of the European Council of Nuclear Cardiology;
  • 2012                 Member of the Cardiovascular Committee of the European Association of Nuclear Medicine;
  • 2010                 Member of the Scientific Committee at the Annual Congresses of the German Society of Nuclear Medicine Medicine and the Society of Nuclear Medicine;
  • 2010                 Member of the Research Group for Nuclear Cardiological Diagnostics of the German Society of Cardiology;
  • 2010                 Member of the Research Group for Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine.

References

External links